Condition
Prostate-Specific Antigen
Total Trials
4
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Unknown2
Not Yet Recruiting1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06608225Not Yet Recruiting
Prognostic Study of Prostate Cancer Via Dynamic Change of PSA in Peritoneal Drainage Fluid After Radical Prostatectomy
NCT05187949Unknown
Promoting Shared-decision Making in Opportunistic Screening for Prostate Cancer
NCT03968692UnknownPrimary
Adequacy of Prostate-Specific Antigen (PSA) Requests
NCT03881709Not ApplicableCompletedPrimary
The Efficacy of Decision Support E-book for Prostate Biopsy Decision Making
Showing all 4 trials